Americana Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Sell
3,958
-3,033
-43% -$1.7M 0.05% 233
2026
Q1
$3.93M Buy
6,991
+2,471
+55% +$1.58M 0.1% 152
2025
Q4
$3.06M Buy
4,520
+3,145
+229% +$2.14M 0.08% 175
2025
Q3
$878K Buy
1,375
+369
+37% +$224K 0.03% 270
2025
Q2
$540K Buy
+1,006
New +$481K 0.02% 294

Other funds holding IDXX

Americana Partners's IDXX Position: Q2 2026 in Review

Americana Partners reduced its Idexx Laboratories (IDXX) stake by 43% in Q2 2026, selling an estimated $1.7M and leaving 3,958 shares worth $2.08M. The position accounts for 0.05% of the portfolio, ranked #233.

Americana Partners first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $3.93M in Q1 2026. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Americana Partners held 3,958 shares of Idexx Laboratories worth $2.08M as of Q2 2026.
  • Americana Partners sold 3,033 Idexx Laboratories shares in Q2 2026, an estimated $1.7M.
  • Idexx Laboratories made up 0.05% of Americana Partners's portfolio in Q2 2026, its #233 holding.
  • Americana Partners first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Americana Partners's Idexx Laboratories position peaked at $3.93M in Q1 2026.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.